Genetic predisposition to accelerated decline of lung function in COPD

International Journal of COPD

Volumn 2, Issue 2, 2007, Pages 117-119

  Molfino, Néstor A ^a  

^a OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

Author keywords

COPD; Genes; Lung function; Smoking

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTIOXIDANT; BRONCHODILATING AGENT; CORTICOSTEROID; EOSINOPHIL CHEMOTACTIC FACTOR; EPOXIDE HYDROLASE; GENE PRODUCT; GLUTATHIONE TRANSFERASE; HEME OXYGENASE 1; INTERSTITIAL COLLAGENASE; ISOPRENALINE; MACROPHAGE ELASTASE; METHACHOLINE;

ALPHA 1 ANTITRYPSIN DEFICIENCY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG RESPONSE; EMPHYSEMA; EXPERIMENTAL ANIMAL; FORCED EXPIRATORY VOLUME; GENE INTERACTION; GENETIC ANALYSIS; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; LUNG FUNCTION; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; RESPIRATORY TRACT INFECTION; REVIEW; RISK ASSESSMENT; RNA INTERFERENCE; SMOKING CESSATION; SMOKING HABIT; VACCINATION;

ALPHA 1-ANTITRYPSIN; ANIMALS; ANTIOXIDANTS; DISEASE PROGRESSION; FORCED EXPIRATORY VOLUME; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG; MATRIX METALLOPROTEINASES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; SMOKING;

EID: 34547628244     PISSN: 11769106     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Agaisse H, Burrack LS, Philips JA, et al. 2005. Genome-wide RNAi screen for host factors required for intracellular bacterial infection. Science, 309:1248-51.
2. Anthonisen NR, Connett JE, Kiley JP, et al. 1994. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA, 272:1497-505.
3. Anthonisen NR, Connett JE, Murray RP. 2002. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med, 166:675-9.
4. Anthonisen NR, Lindgren PG, Tashkin DP, et al. 2005. Bronchodilator response in the lung health study over 11 yrs. Eur Respir J, 26:45-51.
5. Bateman ED, Feldman C, O'Brien J, et al. 2004. Guideline for the management of chronic obstructive pulmonary disease (COPD): 2004 revision. S Afr Med J, 94:559-75.
6. DeMeo DL, Silverman EK. 2004. Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(l)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax, 59:259-64.
7. Donaldson GC, Seemungal TA, Bhowmik A, et al. 2002. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax, 57:847-52.
8. Guenegou A, Leynaert B, Benessiano J, et al. 2006. Association of lung function decline with the heme oxygenase-1 gene promoter microsatellite polymorphism in a general population sample. Results from the European Community Respiratory Health Survey (ECRHS), France. J Med Genet, 43:e43.
9. He JQ, Ruan J, Connett JE, et al. 2002. Antioxidant Gene Polymorphisms and Susceptibility to a Rapid Decline in Lung Function in Smokers. Am J Respir Crit Care Med, 166:323-8.
10. Joos L, He JQ, Shepherdson MB, et al. 2002. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet, 11:569-76.
11. Joos L, Weir TD, Connett JE, et al. 2003. Polymorphisms in the {beta}2 adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokers. Thorax, 58:703-7.
12. Kanner RE, Anthonisen NR, Connett JE. 2001. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir. Crit Care Med, 164:358-64.
13. Koyama H, Geddes DM. 1998. Genes, oxidative stress, and the risk of chronic obstructive pulmonary disease. Thorax, 53:10S-114.
14. Molfino NA. 2004. Genetics of COPD. Chest, 125:1929-40.
15. Nagai K, Betsuyaku T, Kondo T, et al. 2006. Long term smoking with age builds up excessive oxidative stress in bronchoalveolar lavage fluid. Thorax, 61:496-502.
16. Rodriguez F, de la Roza C, Jardi R, et al. 2005. Glutathione S-transferase P1 and lung function in patients with alpha1-antitrypsin deficiency and COPD. Chest, 127:1537-43.
17. Rytila P, Rehn T, Ilumets H, et al. 2006. Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPD. Respir Res, 7:69.
18. Sandford AJ, Chagani T, Weir TD, et al. 2001. Susceptibility genes for rapid decline of lung function in the Lung Health Study. Am J Respir Crit Care Med, 163:469-73.
19. Simmons MS, Connett JE, Nides MA, et al. Smoking reduction and the rate of decline in FEV(1): results from the Lung Health Study. Eur Respir J, 25:1011-17.
20. Smith CAD, Harrison DJ. 1997. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet, 350:630-3.
21. Soriano JB, Kiri VA, Pride NB, et al. 2003. Inhaled corticosteroids with/ without long-acting beta-agonists reduce the risk of rehospitalization and death in COPD patients. Am J Respir Med, 2:67-74.
22. Szafranski W, Cukier A, Ramirez A, et al. 2003. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J, 21:74-81.
23. Takabatake N, Shibata Y, Abe S, et al. 2006. A single nucleotide polymorphism in the CCL 1 gene predicts acute exacerbations in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 174:875-85.
24. 1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 167:1090-5.
25. Xiao D, Wang C, Du MJ, et al. 2004. Relationship between polymorphisms of genes encoding microsomal epoxide hydrolase and glutathione S-transferase P1 and chronic obstructive pulmonary disease. Chin Med J (Engl), 117:661-7.
26. Yamada N, Yamaya M, Okinaga S, et al. 2000. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet, 66:187-95.
27. Yigla M, Berkovich Y, Nagler RM. 2006. Oxidative stress indices in COPD-Broncho-alveolar lavage and salivary analysis. Arch Oral Biol, 52:36-43.